Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001089991-22-000001 | Dec 31st, 2021 12:00AM | Jan 21st, 2022 12:00AM | Jan 21st, 2022 12:00AM | MARKSTON INTERNATIONAL LLC | 1089991 | AKORN, INC. | common stock | 009728106 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | May 6th, 2022 06:59AM | May 6th, 2022 06:59AM | Akorn | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AKORN INC | COM | 009728106 | 11902 | 916960 | SH | DFND | 341676 | 0 | 575284 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Akorn | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AKORN INC | COM | 009728106 | 442 | 34082 | SH | DFND | 33 | 0 | 0 | 34082 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Akorn | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AKORN INC | COM | 009728106 | 18 | 1385 | SH | DFND | 2 | 1351 | 0 | 34 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Akorn | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001089991-21-000004 | Sep 30th, 2021 12:00AM | Nov 2nd, 2021 12:00AM | Nov 2nd, 2021 12:00AM | MARKSTON INTERNATIONAL LLC | 1089991 | AKORN, INC. | common stock | 009728106 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | May 5th, 2022 03:44AM | May 5th, 2022 03:44AM | Akorn | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001089991-21-000003 | Jun 30th, 2021 12:00AM | Aug 5th, 2021 12:00AM | Aug 5th, 2021 12:00AM | MARKSTON INTERNATIONAL LLC | 1089991 | AKORN, INC. | common stock | 009728106 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | May 4th, 2022 09:06PM | May 4th, 2022 09:06PM | Akorn | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001641866-21-000005 | Jun 30th, 2021 12:00AM | Jul 13th, 2021 12:00AM | Jul 13th, 2021 12:00AM | IFP Advisors, Inc | 1641866 | AKORN INC COM | Stock | 009728106 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | 0 | May 4th, 2022 07:08PM | May 4th, 2022 07:08PM | Akorn | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001089991-21-000002 | Mar 31st, 2021 12:00AM | May 14th, 2021 12:00AM | May 14th, 2021 12:00AM | MARKSTON INTERNATIONAL LLC | 1089991 | AKORN, INC. | common stock | 009728106 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | May 4th, 2022 03:44PM | May 4th, 2022 03:44PM | Akorn | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001641866-21-000004 | Mar 31st, 2021 12:00AM | Apr 30th, 2021 12:00AM | Apr 30th, 2021 12:00AM | IFP Advisors, Inc | 1641866 | AKORN INC COM | Stock | 009728106 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | 0 | May 4th, 2022 01:50PM | May 4th, 2022 01:50PM | Akorn | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:akrx | nasdaq:akrx Shareholders | 13F-HR | 0001089991-21-000001 | Dec 31st, 2020 12:00AM | Feb 16th, 2021 12:00AM | Feb 16th, 2021 12:00AM | MARKSTON INTERNATIONAL LLC | 1089991 | AKORN, INC. | common stock | 009728106 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | May 4th, 2022 07:18AM | May 4th, 2022 07:18AM | Akorn | Health Care | Pharmaceuticals & Biotechnology |